Trial of labor following cesarean among patients with oligohydramnios at term: A multicenter retrospective study

The aim of this study was to evaluate the maternal and neonatal outcomes of patients with oligohydramnios attempting a trial of labor after cesarean (TOLAC) versus those who underwent planned repeat cesarean delivery (PRCD). We conducted a multicenter retrospective cohort study of patients with a te...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of gynecology and obstetrics
Main Authors Weiss, Ari, Peled, Tzuria, Rotem, Reut, Sela, Hen Y., Grisaru‐Granovsky, Sorina, Rottenstreich, Misgav
Format Journal Article
LanguageEnglish
Published United States 16.05.2025
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The aim of this study was to evaluate the maternal and neonatal outcomes of patients with oligohydramnios attempting a trial of labor after cesarean (TOLAC) versus those who underwent planned repeat cesarean delivery (PRCD). We conducted a multicenter retrospective cohort study of patients with a term singleton pregnancy following a single low-segment transverse cesarean delivery (CD) and a recent diagnosis of oligohydramnios (maximal vertical pocket <2 cm) between 2017 and 2021. Maternal and neonatal outcomes were compared between patients attempting TOLAC and those opting for PRCD. Univariate analysis was conducted, followed by a multivariate analysis. A total of 352 deliveries were included, of which 278 (79%) attempted TOLAC and 74 (21%) attempted PRCD. The successful vaginal delivery rate for patients who attempted TOLAC was 84.5%. The uterine rupture rate was not significantly different between those attempted TOLAC versus PRCD (1.1% vs. 0%, P = 0.371). However, the rate of hypoglycemia (2.2% vs. 8.1%, P = 0.012) and the composite adverse neonatal outcome was higher among patients with PRCD (11.5% vs. 24.3%, P = 0.005). After controlling for potential confounders, we still demonstrated an independent association between reduced rates of composite adverse neonatal outcome and TOLAC (adjusted odds ratio 0.46, 95% CI: 0.23-0.92, P = 0.028). TOLAC for patients with oligohydramnios appears to be a reasonable alternative and is associated with favorable outcomes. Further large and prospective research on this subject may lead to improved management strategies and better maternal and neonatal outcomes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0020-7292
1879-3479
1879-3479
DOI:10.1002/ijgo.70202